SIPO Biotechnology Co. Ltd.
SIPO Biotechnology Co. Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Preliminary Evaluation of the Safety and Tolerability of SPOT-mRNA01 Subcutaneously Administered in Healthy Subjects | Skin Aging | Not yet recruiting | Phase 1 | 2026-04-23 | NCT06567119 |